ADHD CME

ADHD is a common neuropsychiatric disorder, affecting more than 2-3% of adults in the United States. ADHD is characterized by inattentive and/or hyperactive symptoms. Inattentive symptoms include inattention, distractibility and procrastination whereas hyperactive symptoms include impatience, restlessness, and impulsiveness. The presence of the disorder has a significant impact on health, education, and family situations.

By the end of the session the participant will be able to:

• Summarize the most impactful findings presented at the APA 2019 meeting relating to ADHD in adults related to disease diagnosis and apply them to patient cases.
• Summarize the most impactful findings presented at the APA 2019 meeting relating to ADHD in adults related to evaluation of degree therapeutic success and apply them to patient cases.
• Summarize the most impactful findings presented at the APA 2019 meeting relating to ADHD in adults related to emerging therapies and apply them to patient cases.
• Summarize the most impactful findings presented at the APA 2019 meeting relating to ADHD in adults related to quantifying benefit and risk of disease progression and apply them to patient cases.

Target Audience:

The following healthcare professionals: psychiatrists, and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists who practice in psychiatry; and any other healthcare professionals with an interest in or who clinically encounter pediatric patients with ADHD.

ADHD is a common neuropsychiatric disorder, estimated to affect 7.2% of school age children worldwide and 11% in the US. The presence of the disorder is often not detectable until school workload increases, and it has a significant impact on child and adolescent development, health, education, and family situations. There is evidence of a wide variability in clinicians’ ability to diagnose ADHD, suggesting opportunities for improvement and a gap in care that might be remedied by CME.

By the end of the session the participant will be able to:

• Summarize the most impactful findings presented at the APA 2019 meeting relating to pediatric ADHD related to disease diagnosis and apply them to patient cases.
• Summarize the most impactful findings presented at the APA 2019 meeting relating to pediatric ADHD related to evaluation of degree therapeutic success and apply them to patient cases.
• Summarize the most impactful findings presented at the APA 2019 meeting relating to pediatric ADHD related to emerging therapies and apply them to patient cases.
• Summarize the most impactful findings presented at the APA 2019 meeting relating to pediatric ADHD related to quantifying benefit and risk of disease progression and apply them to patient cases.

Target Audience:

The following healthcare professionals: psychiatrists, primary care physicians, pediatricians; physician assistants, nurse practitioners, nurses, and pharmacists who practice in psychiatry; and any other healthcare professionals with an interest in or who clinically encounter pediatric patients with ADHD.